Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: https://www.cslbehring.com.au/sitemap.xml Disallow: /Sitecore Disallow: /sitecore_files/ Disallow: /sitecore modules/ Disallow: /App_Browsers/ Disallow: /App_config/ Disallow: /App_Data/ Disallow: /temp/ Disallow: /upload/ Disallow: |
Title | CSL Behring Australia | |
Description | CSL opens new Australian Plasma Fractionation CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious |
Keywords | CSL, CSL Behring, Behring, CSLB, CSLBehring |
WebSite | cslbehring.com.au |
Host IP | 12.3.33.229 |
Location | United States |
Site | Rank |
US$1,343,546
Last updated: 2023-05-07 23:24:21
cslbehring.com.au has Semrush global rank of 7,877,887. cslbehring.com.au has an estimated worth of US$ 1,343,546, based on its estimated Ads revenue. cslbehring.com.au receives approximately 155,025 unique visitors each day. Its web server is located in United States, with IP address 12.3.33.229. According to SiteAdvisor, cslbehring.com.au is safe to visit. |
Purchase/Sale Value | US$1,343,546 |
Daily Ads Revenue | US$1,241 |
Monthly Ads Revenue | US$37,206 |
Yearly Ads Revenue | US$446,471 |
Daily Unique Visitors | 10,335 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cslbehring.com.au. | A | 86399 | IP: 12.3.33.229 |
cslbehring.com.au. | NS | 86400 | NS Record: ns3.markmonitor.com. |
cslbehring.com.au. | NS | 86400 | NS Record: ns1.markmonitor.com. |
cslbehring.com.au. | MX | 900 | MX Record: 30 mxb-001a7801.gslb.pphosted.com. |
cslbehring.com.au. | MX | 900 | MX Record: 20 mxa-001a7801.gslb.pphosted.com. |
cslbehring.com.au. | TXT | 3600 | TXT Record: MS=ms28897055 |
cslbehring.com.au. | TXT | 3600 | TXT Record: docusign=af038ec8-3b3c-4fc5-99e6-d79a696c1143 |
cslbehring.com.au. | TXT | 3600 | TXT Record: DFS8UxvmTHLrVT4mCga48hl/jV9zbAcY4lbjES5NS4j6aHjvgXlurTktK98uy56n7OuFNn5QFqIJqp4Cz/GnmA== |
cslbehring.com.au. | TXT | 3600 | TXT Record: dk84bxflfk9v7tkwwwmt86kcn5vkszp1 |
cslbehring.com.au. | TXT | 3600 | TXT Record: MS=ms94755144 |
cslbehring.com.au. | TXT | 3600 | TXT Record: adobe-idp-site-verification=172a177cc81ef0dcfc5a40c2196e122ce7934e069eff7a0a2581b23c8d434895 |
cslbehring.com.au. | TXT | 3600 | TXT Record: 4cmv4n8sw4xw8m07bk1t1vqp3v2pj13r |
cslbehring.com.au. | TXT | 3600 | TXT Record: MS=ms34721587 |
cslbehring.com.au. | TXT | 3600 | TXT Record: v=spf1 include:spf-001a7801.pphosted.com ip4:205.220.189.169 ip4:205.220.188.142 ip4:205.220.189.159 ~all |
Global Selector Partnering Product Orders Contact Us Our Company Our Company Our Promise To Patients Leading the Way on Rare and Serious Diseases Leading the Way on Rare and Serious Diseases White Paper on Rare Disease Awareness The CSL Behring Commitment The CSL Behring Commitment Environment Giving Back Workplace Health and Safety CSL Behring Community Grant Global Leadership Group Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility. Learn More It is our mission to discover, develop, and deliver innovative therapies that improve patients’ quality of life. Learn More Healthcare Portal R&D R&D R&D Capabilities Awards and Grants Awards and Grants Professor Heimburger Award Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise. Learn More See the research that is done to find out if medical treatments can improve people’s health. Learn More on CSL.com Products Products |
HTTP/1.1 301 Moved permanently Location: https://cslbehring.com.au/ Connection: close Cache-Control: no-cache Pragma: no-cache HTTP/1.1 301 Moved Permanently Content-Length: 240 Content-Type: text/html Location: https://www.cslbehring.com.au/ X-Frame-Options: SAMEORIGIN CSL-Asset: PW101 Date: Thu, 28 Oct 2021 22:52:55 GMT Connection: close Strict-Transport-Security: max-age=157680000 Set-Cookie: NSC_JOra11xob1bq0rlcpeqchyc50zbpset=ffffffffaf1c1f1b45525d5f4f58455e445a4a42378b;Version=1;path=/;secure;httponly HTTP/1.1 200 OK Cache-Control: no-cache, no-store Pragma: no-cache Content-Length: 102752 Content-Type: text/html; charset=utf-8 Expires: -1 Set-Cookie: ASP.NET_SessionId=dk20wiyu1m11xi11fhjuwqy2; path=/; HttpOnly; SameSite=Lax Set-Cookie: SC_ANALYTICS_GLOBAL_COOKIE=ea8d1df4875f4ade89b04ff5a4f25546|False; expires=Sun, 26-Oct-2031 22:52:56 GMT; path=/; HttpOnly Set-Cookie: CookiePrivacyBanner=; expires=Fri, 28-Oct-2022 22:52:56 GMT; path=/ Set-Cookie: sxa_site=website_cslbehring_australia; path=/ X-Frame-Options: SAMEORIGIN CSL-Asset: PW102 Date: Thu, 28 Oct 2021 22:52:56 GMT Strict-Transport-Security: max-age=157680000 Set-Cookie: NSC_mcwt_xxx.dtmcfisjoh.dpn.bv_umt=ffffffffaf1c1f1a45525d5f4f58455e445a4a42378b;Version=1;path=/;secure;httponly |